Funding
Accelerator investment · Healthtech

ND Lens joins BGV portfolio to streamline ADHD assessments

ND Lens develops an AI-assisted ADHD assessment platform that collects patient responses and prepares evidence-linked draft reports for clinicians to review.

By RoundOS Funding desk

Bethnal Green Ventures named ND Lens among the companies joining its Spring 2026 investment portfolio on April 21. The investment is part of BGV's Tech for Good programme for early-stage businesses.

From patient questionnaire to clinical report

ND Lens combines patient questionnaires with AI-assisted analysis and draft reporting for ADHD assessments. Its workflow keeps clinician review and sign-off at the centre while reducing the administrative work around each assessment.

Funding history

Accelerator investment · This roundUndisclosed

Sources

  1. Announcing our Spring 2026 cohortbethnalgreenventures.com · Apr 21, 2026
  2. ndlens.com

Similar rounds

All Healthtech rounds →
Nanochap

Develops retinal and cortical brain-computer interfaces that use electrical stimulation to create artificial visual perception.

CN¥500MSeries C+ · Nov 3, 2026
1nhaler

1nhaler develops a compact, single-dose dry powder inhaler made predominantly from cardboard.

£2.2MFollow-on funding · Nov 3, 2026
Esonitro

Esonitro develops flexible neural electrodes and brain-computer interface technology, including its movable NeuroWorm electrode.

~CN¥100MAngel+ · Nov 2, 2026
OBSESS

OBSESS connects people with sports venues, gyms, trainers, nutrition providers and fitness brands through a shared digital marketplace.

~₹30MAngel · Nov 2, 2026

Related